US2012142651A1PendingUtilityA1
Method of treatment of allergic rhinitis
Est. expiryFeb 4, 2022(expired)· nominal 20-yr term from priority
Inventors:Keith BiggadikeIan BuxtonSteven CooteRosalyn Kay NiceKenton ReedAmyn SayaniAvinash Chander Sharma
A61P 37/08A61P 5/44A61P 29/00A61K 9/0043A61K 31/58A61K 9/0078A61P 11/02A61K 47/38A61K 31/56A61K 45/06
56
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
There is provided a method of treatment of allergic rhinitis which comprises administering to a patient a pharmaceutically acceptable amount of a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I) or a solvate thereof, wherein the administration is once-per-day and intranasal, and the total daily dose of the compound (I) is 50 to 100 μg.
Claims
exact text as granted — not AI-modified1 . A method of treatment of allergic rhinitis which comprises administering to a patient a pharmaceutically acceptable amount of a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I)
or a solvate thereof, wherein the administration is once-per-day and intranasal, and the total daily dose of the compound (I) is 50 to 100 μg.Join the waitlist — get patent alerts
Track US2012142651A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.